1[1]Bui K Q, Banevicius M A, Nightingale C H,et al. In vitro and invo inflence of adjunct clarithromycin on the treatment of mucoid pseudomonas aeruginosa[J].J Antimicrob Chemother, 2000,45(1):57-62.
2[2]Numazaki K, Sakamoto Y, Umetsu M, et al. Therapeutic effect of clarithromycin for respiratory tract infections in children caused by chlamydia pneumoniae[J].Int J Antimicrob Agents, 2000,13(3):219-222.
3[3]Heffelfinger J D, Dowell S F, Jorgensen J H,et al. Manag ement of community acquired pneumonia in the era of pneumococcal resistance: a report from the drug resistance streptococcus pneumoniae therapeutic working group[J]. Arch Intern Med, 2000,160(10):1399-1408.
